A recent study identified two abundant populations of tau in the CSF; tau1‐123, which is generated during physiological tau processing, and, tau1‐224 detected in NFTs and increased in the CSF of AD patients (Cicognola et al., 2019) (Table 1). The gene discussed is MAPT; the disease is Alzheimer disease.